Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fridkin

Showing results (211-220 of 515) with videos related to

Pageof 52
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2001
A beta -hairpin structure in a 13-mer peptide that binds alpha -bungarotoxin with high affinity and neutralizes its toxicityT Scherf, R Kasher, M Balass, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2001
Antigenicity and immunogenicity of an intracellular delivery system of major histocompatibility complex class I epitopes that bypasses proteasome processingB Tirosh, M Fridkin, E Tzehoval, et al.
Endocrinology|February 25, 2006
The substrate-binding domain of 21-hydroxylase, the main autoantigen in autoimmune Addison's disease, is an immunodominant T cell epitopeEystein S Husebye, Eirik Bratland, Geir Bredholt, et al.
Physiology & Behavior|December 26, 2012
'Roid rage in rats? Testosterone effects on aggressive motivation, impulsivity and tyrosine hydroxylaseRuth I Wood, Abigail Armstrong, Vlad Fridkin, et al.
European Journal of Biochemistry|July 1, 1994
Inhibition of cell adhesion to glycoproteins of the extracellular matrix by peptides corresponding to serum amyloid A. Toward understanding the physiological role of an enigmatic proteinL Preciado-Patt, D Levartowsky, M Prass, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 4, 2009
Engineering prolonged-acting prodrugs employing an albumin-binding probe that undergoes slow hydrolysis at physiological conditionsK Sasson, Y Marcus, V Lev-Goldman, et al.
Therapeutic Delivery|July 27, 2012
Establishing the principle of reversibility in peptide/protein and small-molecule therapyYoram Shechter, Keren Sasson, Yonit Marcus, et al.
Analytical Methods : Advancing Methods and Applications|March 8, 2024
Highly sensitive chemiluminescence sensors for the detection and differentiation of chemical warfare agentsOrit Redy Keisar, Alexander Pevzner, Gil Fridkin, et al.
Journal of Medicinal Chemistry|September 17, 2004
Reversible PEGylation: a novel technology to release native interferon alpha2 over a prolonged time periodTal Peleg-Shulman, Haim Tsubery, Marina Mironchik, et al.
JAMA Internal Medicine|September 23, 2016
Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012James Baggs, Scott K Fridkin, Lori A Pollack, et al.
Pageof 52

Showing results (211-220 of 515) with videos related to

Sort By:
Pageof 52
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2001
A beta -hairpin structure in a 13-mer peptide that binds alpha -bungarotoxin with high affinity and neutralizes its toxicityT Scherf, R Kasher, M Balass, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2001
Antigenicity and immunogenicity of an intracellular delivery system of major histocompatibility complex class I epitopes that bypasses proteasome processingB Tirosh, M Fridkin, E Tzehoval, et al.
Endocrinology|February 25, 2006
The substrate-binding domain of 21-hydroxylase, the main autoantigen in autoimmune Addison's disease, is an immunodominant T cell epitopeEystein S Husebye, Eirik Bratland, Geir Bredholt, et al.
Physiology & Behavior|December 26, 2012
'Roid rage in rats? Testosterone effects on aggressive motivation, impulsivity and tyrosine hydroxylaseRuth I Wood, Abigail Armstrong, Vlad Fridkin, et al.
European Journal of Biochemistry|July 1, 1994
Inhibition of cell adhesion to glycoproteins of the extracellular matrix by peptides corresponding to serum amyloid A. Toward understanding the physiological role of an enigmatic proteinL Preciado-Patt, D Levartowsky, M Prass, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 4, 2009
Engineering prolonged-acting prodrugs employing an albumin-binding probe that undergoes slow hydrolysis at physiological conditionsK Sasson, Y Marcus, V Lev-Goldman, et al.
Therapeutic Delivery|July 27, 2012
Establishing the principle of reversibility in peptide/protein and small-molecule therapyYoram Shechter, Keren Sasson, Yonit Marcus, et al.
Analytical Methods : Advancing Methods and Applications|March 8, 2024
Highly sensitive chemiluminescence sensors for the detection and differentiation of chemical warfare agentsOrit Redy Keisar, Alexander Pevzner, Gil Fridkin, et al.
Journal of Medicinal Chemistry|September 17, 2004
Reversible PEGylation: a novel technology to release native interferon alpha2 over a prolonged time periodTal Peleg-Shulman, Haim Tsubery, Marina Mironchik, et al.
JAMA Internal Medicine|September 23, 2016
Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012James Baggs, Scott K Fridkin, Lori A Pollack, et al.
Pageof 52